$65.29
Price
$12.6B
Market Cap
176.5
P/E Ratio
10.1
Forward P/E
$0.37
EPS (TTM)
—
Dividend Yield
$874M
Cash
$606M
Total Debt
194M
Shares Out
$49.26
$70.98
52-Week Range
Institutional Ownership of Biomarin Pharmaceutical Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Biomarin Pharmaceutical Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2024-Q1 | |||||
| SELL | EXIT | — | — | $88.54 | |
| 2023-Q4 | |||||
| BUY | NEW | 385.0K | $37M | $87.52 | |
Insider Trading for Biomarin Pharmaceutical Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.